← Holders
venBio Partners LLC
What venBio Partners LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1776382 · Filed Nov 16, 2026
- Positions
- 9
- Reported value
- $495.9M
- Opened
- 3
- Closed
- 1
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$176.4M6 positions
- Dec 31, 2025$216.3M6 positions
- Mar 31, 2026$280.6M6 positions
- Jun 30, 2026$519.4M7 positions
- Sep 30, 2026$495.9M9 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
PBLSParabilis Medicines, Inc. | 5.3M | ±0% | $170.1M | 34.3% |
PHVSPharvaris N.V. | 4.5M | −4.0% | $141.4M | 28.5% |
ATTOAttovia Therapeutics, Inc. | 4.2M | New | $71.7M | 14.5% |
ACHVAchieve Life Sciences, Inc. | 5.9M | ±0% | $47.9M | 9.6% |
ALMSAlumis Inc. | 4.2M | −7.4% | $31M | 6.2% |
ALXOALX Oncology Holdings Inc | 12.9M | ±0% | $17.9M | 3.6% |
YARWYarrow Bioscience, Inc. | 554.8K | New | $12.5M | 2.5% |
LYELLyell Immunopharma, Inc. | 337.7K | ±0% | $3.3M | 0.7% |
LSTALisata Therapeutics, Inc. | 156.5K | New | $225.3K | 0.1% |